Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Prostate Cancer

  Free Subscription


26.08.2024

1 Am J Clin Oncol
1 Am J Pathol
1 BJU Int
1 BMC Cancer
1 Clin Cancer Res
4 Eur Urol
1 Int J Urol
1 J Nucl Med
1 J Urol
1 Magn Reson Med
1 Oncogene
6 Prostate
1 Radiology
1 Urology


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Clin Oncol

  1. RITTER AR, Prasad RN, Jhawar SR, Bazan JG, et al
    Hypofractionated Radiation Therapy: A Cross-sectional Survey Study of US Radiation Oncologists.
    Am J Clin Oncol. 2024;47:434-438.
    PubMed         Abstract available


    Am J Pathol

  2. BRANDT MP, Vakhrusheva O, Hackl H, Daher T, et al
    Inhibition of the sterol regulatory element binding protein (SREB-P) SREBF-1 overcomes docetaxel resistance in advanced prostate cancer.
    Am J Pathol. 2024 Aug 19:S0002-9440(24)00295.
    PubMed         Abstract available


    BJU Int

  3. ONG WL, Krishnaprasad K, Bensley J, Steeper M, et al
    Population-based prostate cancer outcomes registries - what have we learned and where are we heading?
    BJU Int. 2024 Aug 19. doi: 10.1111/bju.16487.
    PubMed        


    BMC Cancer

  4. XIAO Y, Lai C, Hu J, Mulati Y, et al
    Integrative analysis regarding the correlation between collagen-related genes and prostate cancer.
    BMC Cancer. 2024;24:1038.
    PubMed         Abstract available


    Clin Cancer Res

  5. CHAUHAN PS, Alahi I, Sinha S, Ledet EM, et al
    Genomic and epigenomic analysis of plasma cell-free DNA identifies stemness features associated with worse survival in lethal prostate cancer.
    Clin Cancer Res. 2024 Aug 23. doi: 10.1158/1078-0432.CCR-24-1658.
    PubMed         Abstract available


    Eur Urol

  6. QI F
    Re: Wesley R. Armstrong, Amar U. Kishan, Kiara M. Booker, et al. Impact of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography on Prostate Cancer Salvage Radiotherapy Management: Results from a Prospective Multicenter R
    Eur Urol. 2024 Aug 21:S0302-2838(24)02557-0. doi: 10.1016/j.eururo.2024.
    PubMed        

  7. MAY M, Albersen M, Brookman-May S
    Re: Influential Factors Impacting Treatment Decision-making and Decision Regret in Patients with Localized or Locally Advanced Prostate Cancer: A Systematic Literature Review.
    Eur Urol. 2024 Aug 19:S0302-2838(24)02552-1. doi: 10.1016/j.eururo.2024.
    PubMed        

  8. BRATT O
    Re: Prostate Cancers in the Prostate-specific Antigen Interval of 1.8-3 ng/ml: Results from the Goteborg-2 Prostate Cancer Screening Trial.
    Eur Urol. 2024 Aug 17:S0302-2838(24)02523-5. doi: 10.1016/j.eururo.2024.
    PubMed        

  9. CHEN DC, Park H, McVey A, Lawrentschuk N, et al
    Re: Artificial Intelligence and Radiologists in Prostate Cancer Detection on MRI (PI-CAI): An International, Paired, Non-inferiority, Confirmatory Study.
    Eur Urol. 2024 Aug 17:S0302-2838(24)02520-X. doi: 10.1016/j.eururo.2024.
    PubMed        


    Int J Urol

  10. MIURA H, Hatakeyama S, Tabata R, Fujimori D, et al
    Treatment trends in patients with de novo metastatic prostate cancer in the era of upfront combination therapy.
    Int J Urol. 2024 Aug 23. doi: 10.1111/iju.15550.
    PubMed         Abstract available


    J Nucl Med

  11. THIN P, Hotta M, Gafita A, Grogan T, et al
    Clinical Factors That Influence Repeat (68)Ga-PSMA-11 PET/CT Scan Positivity in Patients with Recurrent Prostate Cancer Under Observation After a Negative (68)Ga-PSMA-11 PET/CT Scan: A Single-Center Retrospective Study.
    J Nucl Med. 2024 Aug 21:jnumed.124.267591. doi: 10.2967/jnumed.124.267591.
    PubMed         Abstract available


    J Urol

  12. SUN R, Shan D
    Letter: Clinician-Reported Management Recommendations in Response to Universal Germline Genetic Testing in Patients With Prostate Cancer.
    J Urol. 2024 Aug 23:101097JU0000000000004215. doi: 10.1097/JU.0000000000004215.
    PubMed        


    Magn Reson Med

  13. SEN S, Singh S, Pye H, Moore CM, et al
    ssVERDICT: Self-supervised VERDICT-MRI for enhanced prostate tumor characterization.
    Magn Reson Med. 2024;92:2181-2192.
    PubMed         Abstract available


    Oncogene

  14. YU J, Zhang M, Li T, Gao W, et al
    Monoacylglycerol lipase blockades the senescence-associated secretory phenotype by interfering with NF-kappaB activation and promotes docetaxel efficacy in prostate cancer.
    Oncogene. 2024 Aug 18. doi: 10.1038/s41388-024-03132.
    PubMed         Abstract available


    Prostate

  15. SAHEB SHARIF-ASKARI F, Al-Shahrabi R, Al Shareef Z
    Response to the letter to the editor: Incidence and risk factors of prostate cancer among the Northern and Eastern parts of the United Arab Emirates population.
    Prostate. 2024 Aug 21. doi: 10.1002/pros.24779.
    PubMed        

  16. SWAMI U, Xie B, Young C, Ramaswamy K, et al
    Real-world prevalence of adverse events with first-line systemic therapies among patients with metastatic castration-sensitive prostate cancer.
    Prostate. 2024 Aug 20. doi: 10.1002/pros.24777.
    PubMed         Abstract available

  17. LI EV, Lee MS, Guo J, Dean N, et al
    Modern predictors and management of incidental prostate cancer at holmium enucleation of prostate.
    Prostate. 2024 Aug 18. doi: 10.1002/pros.24781.
    PubMed         Abstract available

  18. HSIEH CL, Do AD, Hsueh CY, Raboshakga MO, et al
    L1CAM mediates neuroendocrine phenotype acquisition in prostate cancer cells.
    Prostate. 2024 Aug 18. doi: 10.1002/pros.24782.
    PubMed         Abstract available

  19. WANG J, Lao Y, Guan X, Li Z, et al
    Incidence and risk factors of prostate cancer among the Northern and Eastern parts of the United Arab Emirates population.
    Prostate. 2024 Aug 21. doi: 10.1002/pros.24671.
    PubMed        

  20. TANEGASHIMA T, Shiota M, Eto M
    Reply to Letter to the Editor on "Impact of proton pump inhibitors on the efficacy of androgen receptor signaling inhibitors in metastatic castration-resistant prostate cancer patients".
    Prostate. 2024 Aug 21. doi: 10.1002/pros.24784.
    PubMed        


    Radiology

  21. KUO PH, Morris MJ, Hesterman J, Kendi AT, et al
    Quantitative (68)Ga-PSMA-11 PET and Clinical Outcomes in Metastatic Castration-resistant Prostate Cancer Following (177)Lu-PSMA-617 (VISION Trial).
    Radiology. 2024;312:e233460.
    PubMed         Abstract available


    Urology

  22. CHEN L, Fu Z, Dong Q, Zheng F, et al
    Machine Learning-Based Nomograms for Predicting Clinical Stages of Initial Prostate Cancer: A Multicenter Retrospective Study.
    Urology. 2024 Aug 14:S0090-4295(24)00656-3. doi: 10.1016/j.urology.2024.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.